Center-Authored Papers

Filters: Author is Porter, Peggy L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Amon LM, Pitteri SJ, Li CI, McIntosh MW, Ladd J, Disis ML, Porter PL, Wong C-H, Zhang Q, Prentice RL et al..  2012.  Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.. Cancer research. Abstract
Atkinson C, Ray RM, Li W, Lin M-G, Gao D, Shannon J, Stalsberg H, Porter PL, Frankenfeld CL, Wähälä K et al..  2016.  Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China.. Nutrition research (New York, N.Y.). 36(8):863-871. Abstract
B
Beaber EF, Malone KE, Tang M-TC, Barlow WE, Porter PL, Daling JR, Li CI.  2014.  Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(5):755-64. Abstract
Beaber EF, Holt VL, Malone KE, Porter PL, Daling JR, Li CI.  2008.  Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(12):3427-34. Abstract
Bluestein BM, Morrish F, Graham DJ, Guenthoer J, Hockenbery D, Porter PL, Gamble LJ.  2016.  An unsupervised MVA method to compare specific regions in human breast tumor tissue samples using ToF-SIMS.. The Analyst. 141(6):1947-57. Abstract
C
Cai X, Dai Z, Reeves RS, Caballero-Benitez A, Duran KL, Delrow JJ, Porter PL, Spies T, Groh V.  2014.  Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells.. PloS one. 9(10):e108942. Abstract
Chen L, Cook LS, Tang M-TC, Porter PL, Hill DA, Wiggins CL, Li CI.  2016.  Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.. Breast cancer research and treatment. 157(3):545-54. Abstract
D
Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, Malone KE.  2009.  Risk factors for triple-negative breast cancer in women under the age of 45 years.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(4):1157-66. Abstract
G
Gadi VK, Malone KE, Guthrie KA, Porter PL, Nelson JL.  2008.  Case-control study of fetal microchimerism and breast cancer.. PloS one. 3(3):e1706. Abstract
Guenthoer J, Diede SJ, Tanaka H, Chai X, Hsu L, Tapscott SJ, Porter PL.  2012.  Assessment of palindromes as platforms for DNA amplification in breast cancer.. Genome research. 22(2):232-45. Abstract
H
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract
Harigopal M, Barlow WE, Tedeschi G, Porter PL, Yeh I-T, Haskell C, Livingston R, Hortobagyi GN, Sledge G, Shapiro C et al..  2010.  Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.. The American journal of pathology. 176(4):1639-47. Abstract
L
Li CI, Daling JR, Porter PL, Tang M-TC, Malone KE.  2009.  Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(32):5312-8. Abstract
Li CI, Daling JR, Tang M-TC, Haugen KL, Porter PL, Malone KE.  2013.  Use of Antihypertensive Medications and Breast Cancer Risk Among Women Aged 55 to 74 Years.. JAMA internal medicine. 173(17):1629-37. Abstract
Li CI, Daling JR, Porter PL, Tang M-TC, Malone KE.  2009.  Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer.. Cancer research. 69(17):6865-70. Abstract
Li CI, Beaber EF, Tang M-TC, Porter PL, Daling JR, Malone KE.  2013.  Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.. Breast cancer research and treatment. 137(2):579-87. Abstract
Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR.  2008.  Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(1):43-50. Abstract
Li CI, Daling JR, Haugen KL, Tang MTC, Porter PL, Malone KE.  2014.  Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.. Breast cancer research and treatment. 145(2):481-9. Abstract
Li CI, Beaber EF, Tang M-TC, Porter PL, Daling JR, Malone KE.  2012.  Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20-44 years of age.. Cancer research. Abstract
Loo LWM, Ton C, Wang Y-W, Grove DI, Bouzek H, Vartanian N, Lin M-G, Yuan X, Lawton TL, Daling JR et al..  2008.  Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.. Genes, chromosomes & cancer. 47(12):1049-66. Abstract
Loo LWM, Wang Y, Flynn EM, Lund MJ, Bowles EAJ, Buist DSM, Liff JM, Flagg EW, Coates RJ, Eley WJ et al..  2011.  Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women.. Breast cancer research and treatment. 127(1):297-308. Abstract
Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SGA, Eley WJ.  2009.  Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.. Breast cancer research and treatment. 113(2):357-70. Abstract
M
Malone KE, Daling JR, Doody DR, O'Brien C, Resler A, Ostrander EA, Porter PL.  2011.  Family History of Breast Cancer in Relation to Tumor Characteristics and Mortality in a Population-Based Study of Young Women with Invasive Breast Cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(12):2560-2571. Abstract
Mathes RW, Malone KE, Daling JR, Porter PL, Li CI.  2008.  Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(1):67-72. Abstract
Mathes RW, Malone KE, Daling JR, Davis S, Lucas SM, Porter PL, Li CI.  2008.  Migraine in postmenopausal women and the risk of invasive breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(11):3116-22. Abstract